Paranovus 20-F: $15.7M Loss, Material Weaknesses, Auditor Change
PAVS sits 76% above its 52-week low of $3.76.
Summary
Paranovus reported a $15.7 million net loss for fiscal 2026, disclosed material weaknesses in internal controls, and changed auditors. The company also completed a $33 million asset acquisition after year-end.
Key Events · Earnings and Guidance · PAVS
-
Net Loss of $15.7 Million
Revenue grew to $14.6 million from $71,542, but net loss widened to $15.7 million from $8.3 million, driven by $6.6 million goodwill impairment and $4.7 million asset impairment.
-
Material Weaknesses in Internal Controls
Management concluded internal control over financial reporting was not effective as of March 31, 2026, citing insufficient U.S. GAAP expertise and lack of technical knowledge in business combinations and valuations.
-
Auditor Change
HHL LLP resigned effective June 26, 2026, and HCL, PLLC was appointed as the new independent auditor.
-
Heyviva Acquisition for $33 Million
On August 5, 2026, the company completed the acquisition of Heyviva assets for $33 million in cash, funded after fiscal year-end.
Analysis · PAVS · Technology
The annual report reveals a $15.7 million net loss driven by $11.3 million in goodwill and asset impairments, alongside material weaknesses in internal controls and an auditor change. These are significant red flags for a company with a market cap of only $5.7 million. The Heyviva acquisition for $33 million, closed after fiscal year-end, adds further financial strain.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 37.5% of the 3362 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PAVS was trading at $6.61 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.7M. The 52-week trading range was $3.76 to $148,800.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.